167 related articles for article (PubMed ID: 15133662)
1. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer.
Peng L; Ning J; Meng L; Shou C
J Cancer Res Clin Oncol; 2004 Sep; 130(9):521-6. PubMed ID: 15133662
[TBL] [Abstract][Full Text] [Related]
2. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
[TBL] [Abstract][Full Text] [Related]
3. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of monoclonal antibody against protein tyrosine phosphatase PRL-3.
Peng L; Li Y; Meng L; Shou C
Hybrid Hybridomics; 2004 Feb; 23(1):23-7. PubMed ID: 15000845
[TBL] [Abstract][Full Text] [Related]
5. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
[TBL] [Abstract][Full Text] [Related]
6. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region of tumor and metastases of colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Ustymowicz M
Adv Med Sci; 2011; 56(1):39-43. PubMed ID: 21555304
[TBL] [Abstract][Full Text] [Related]
8. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
[TBL] [Abstract][Full Text] [Related]
9. The expression of the phosphatase regenerating liver 3 gene is associated with outcome in patients with colorectal cancer.
Tamagawa H; Oshima T; Yoshihara K; Watanabe T; Numata M; Yamamoto N; Tuschida K; Shiozawa M; Morinaga S; Akaike M; Masuda M; lmada T
Hepatogastroenterology; 2012 Oct; 59(119):2122-6. PubMed ID: 22440248
[TBL] [Abstract][Full Text] [Related]
10. PRL-3 expression in metastatic cancers.
Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
[TBL] [Abstract][Full Text] [Related]
11. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
Wallin AR; Svanvik J; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):452-8. PubMed ID: 16626893
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
[TBL] [Abstract][Full Text] [Related]
14. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival.
Oliveira LA; Artigiani-Neto R; Waisberg DR; Fernandes LC; Lima Fde O; Waisberg J
Arq Gastroenterol; 2010; 47(4):361-7. PubMed ID: 21225146
[TBL] [Abstract][Full Text] [Related]
15. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.
Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X
Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129
[TBL] [Abstract][Full Text] [Related]
16. A phosphatase associated with metastasis of colorectal cancer.
Saha S; Bardelli A; Buckhaults P; Velculescu VE; Rago C; St Croix B; Romans KE; Choti MA; Lengauer C; Kinzler KW; Vogelstein B
Science; 2001 Nov; 294(5545):1343-6. PubMed ID: 11598267
[TBL] [Abstract][Full Text] [Related]
17. [Role of molecular adjuvants TBhsp and MT in the preparation of monoclonal antibody against phosphatase of regenerating liver-3].
Cao Y; Lv J; Meng L; Qu L; Shou C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):614-7, 626. PubMed ID: 24909283
[TBL] [Abstract][Full Text] [Related]
18. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.
Nakayama N; Yamashita K; Tanaka T; Kawamata H; Ooki A; Sato T; Nakamura T; Watanabe M
Clin Exp Metastasis; 2016 Jan; 33(1):3-13. PubMed ID: 26563151
[TBL] [Abstract][Full Text] [Related]
19. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases.
Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A
Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584
[TBL] [Abstract][Full Text] [Related]
20. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
